Markets › India › NSE › ZIMLAB

Zim Laboratories Ltd

NSE:ZIMLABHealthcare

₹138.17−4.55%At closeAt close · Mon 19 Oct · ≈ AED 5.34 · Market cap $78.3M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	48.2%	50.5%	22.7%	50.6%	19.5%	16.7%	—	—
Operating margin	8.0%	6.8%	7.8%	29.9%	5.4%	1.5%	1.5%	+0.0 pts
Net margin	2.4%	4.4%	6.1%	4.7%	3.3%	1.6%	1.6%	+0.0 pts
EBITDA margin	11.6%	13.7%	14.6%	12.4%	13.2%	6.9%	—	—
Return on equity	4.6%	8.3%	12.2%	7.2%	4.8%	2.0%	2.0%	−0.0 pts
Return on assets	2.3%	4.3%	7.2%	3.9%	2.6%	1.1%	1.1%	+0.0 pts
Return on capital employed	13.5%	11.5%	13.5%	38.2%	6.6%	1.6%	—	—
Debt / equity	0.5×	0.3×	0.3×	0.5×	0.5×	0.4×	0.4×	−0.0%
Debt / assets	25.3%	15.6%	18.2%	25.0%	25.0%	23.4%	—	—
Interest coverage	2.3×	2.7×	5.6×	15.9×	1.8×	0.4×	—	—
Current ratio	1.4×	1.5×	1.7×	1.4×	1.4×	1.4×	1.4×	+0.0%
Quick ratio	1.0×	0.9×	1.2×	0.9×	0.9×	1.0×	—	—
Cash ratio	0.0×	0.0×	0.1×	0.1×	0.0×	0.1×	0.1×	+0.0%
Asset turnover	0.9×	1.0×	1.2×	0.8×	0.8×	0.7×	—	—
Inventory turnover	2.9×	2.1×	5.7×	2.2×	3.5×	3.3×	—	—
Receivables turnover	3.8×	3.4×	4.0×	3.6×	3.5×	3.4×	—	—
Dividend payout	0.3%	1.2%	0.2%	0.3%	0.5%	1.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.